Clinical Research Directory
Browse clinical research sites, groups, and studies.
Detection and Prevention of Cancer-Related Cardiovascular Toxicity Registry
Sponsor: University of Bologna
Summary
This study is being done in order to assess the cardiovascular events known as cardiovascular toxicity of chemotherapy agents and radiotherapy protocols in cancer subjects to identify risk prediction, prevention and treatment of cancer therapy-related cardiovascular toxicity and cancer therapy-related cardiac dysfunction
Official title: Detection and Prevention of Cancer-Related Cardiovascular Toxicity Registry (ISACS CARDIONCO-PREDICT)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
10000
Start Date
2025-05-01
Completion Date
2026-12-31
Last Updated
2025-06-19
Healthy Volunteers
No
Conditions
Interventions
Prospective validation of the HFA-ICOS risk score in a subset of subjects with newly diagnosed breast cancer and undergoing treatment with anthracyclines analogues with or without radiotherapy
Follow-up visits at baseline, 3-months, and 1-year
Locations (5)
University of Bologna
Bologna, Italy
Azienda Ospedaliera Universitaria Policlinico "Paolo Giaccone"
Palermo, Italy
Ss. Cyril and Methodius University in Skopje, University Clinic
Skopje, North Macedonia
University of Belgrade, Clinical Center of Serbia
Belgrade, Serbia
University of Belgrade, Clinical Hospital Center Bezanijska kosa
Belgrade, Serbia